Search research articles
Contact Us
Filters
Showing results (31-40 of 301) with videos related to
Page
of 31
Sort By:
Gynecologic Oncology
|
March 27, 2012
Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer
Laura J Havrilesky, Craig F Garfield, Jason C Barnett, et al.
Gynecologic Oncology Reports
|
December 27, 2016
Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists
Sarah M Crafton, Courtney D Lynch, David E Cohn, et al.
Obstetrics and Gynecology
|
June 2, 2007
Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma
David E Cohn, Warner K Huh, Jeffrey M Fowler, et al.
Gynecologic Oncology
|
September 4, 2015
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
Linda R Duska, James J Java, David E Cohn, et al.
Gynecologic Oncology Reports
|
October 2, 2015
WWP2 and its association with PTEN in endometrial cancer
Aine E Clements, Veronica Bravo, Christopher Koivisto, et al.
Gynecologic Oncology
|
April 15, 2022
Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis
David A Barrington, Courtney Riedinger, Paulina J Haight, et al.
Gynecologic Oncology
|
August 2, 2015
Bariatric surgery as a means to decrease mortality in women with type I endometrial cancer - An intriguing option in a population at risk for dying of complications of metabolic syndrome
Robert Neff, Laura J Havrilesky, Junzo Chino, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
February 12, 2017
Recruiting Endometrial Cancer Survivors to Studies Examining Lifestyle Behaviors and Quality of Life: Challenges Faced and Lessons Learned
Alexander R Lucas, Brian C Focht, David E Cohn, et al.
Integrative Cancer Therapies
|
September 16, 2016
A Mindfulness-Based Lifestyle Intervention for Obese, Inactive Endometrial Cancer Survivors: A Feasibility Study
Alexander R Lucas, Brian C Focht, David E Cohn, et al.
Archives of Pathology & Laboratory Medicine
|
August 27, 2005
CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites
Lindsey B De Lott, Carl Morrison, Saul Suster, et al.
Page
of 31
Search research articles
Search
Showing results (31-40 of 301) with videos related to
Sort By:
Page
of 31
Gynecologic Oncology
|
March 27, 2012
Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer
Laura J Havrilesky, Craig F Garfield, Jason C Barnett, et al.
Gynecologic Oncology Reports
|
December 27, 2016
Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists
Sarah M Crafton, Courtney D Lynch, David E Cohn, et al.
Obstetrics and Gynecology
|
June 2, 2007
Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma
David E Cohn, Warner K Huh, Jeffrey M Fowler, et al.
Gynecologic Oncology
|
September 4, 2015
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
Linda R Duska, James J Java, David E Cohn, et al.
Gynecologic Oncology Reports
|
October 2, 2015
WWP2 and its association with PTEN in endometrial cancer
Aine E Clements, Veronica Bravo, Christopher Koivisto, et al.
Gynecologic Oncology
|
April 15, 2022
Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis
David A Barrington, Courtney Riedinger, Paulina J Haight, et al.
Gynecologic Oncology
|
August 2, 2015
Bariatric surgery as a means to decrease mortality in women with type I endometrial cancer - An intriguing option in a population at risk for dying of complications of metabolic syndrome
Robert Neff, Laura J Havrilesky, Junzo Chino, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
February 12, 2017
Recruiting Endometrial Cancer Survivors to Studies Examining Lifestyle Behaviors and Quality of Life: Challenges Faced and Lessons Learned
Alexander R Lucas, Brian C Focht, David E Cohn, et al.
Integrative Cancer Therapies
|
September 16, 2016
A Mindfulness-Based Lifestyle Intervention for Obese, Inactive Endometrial Cancer Survivors: A Feasibility Study
Alexander R Lucas, Brian C Focht, David E Cohn, et al.
Archives of Pathology & Laboratory Medicine
|
August 27, 2005
CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites
Lindsey B De Lott, Carl Morrison, Saul Suster, et al.
Page
of 31